The short version

One of the fastest-growing and least standardized categories. Regulatory status differs sharply by product and country, and the evidence ranges from controlled trials to marketing.

What the cost figure means

No reliable national estimate. Sold per session or series by each provider; no society publishes an average. Confirm exactly which product is being injected before comparing prices.

Advertised prices on file

$300–$500 per syringe (HA skin-quality product)

Skinvive as listed on two menus; polynucleotide and exosome products were sold as add-ons ($250–$300) rather than priced as stand-alone injections.

Read from 3 published U.S. clinic menus on September 1, 2026. A convenience sample, not a national survey: prices vary by city and provider, packages are usually cheaper per session, and menus change without notice.

Total course = per-session fee × planned sessions + consultation + product, cartridge, or serum + anesthesia or facility + prescriptions and aftercare + expected maintenance. Ask for the plan price in writing.

Healing and results timeline

Appointment
About 20–40 minutes
Downtime
Small bumps for a day or two; bruising possible
Healing
Injection bumps settle within 24–48 hours; bruises fade within a week.
Results appear
Gradual, usually judged at 4–8 weeks
Duration and maintenance
Product dependent, often several months

Benefits, limitations, and risks

Realistic benefits

  • Subtle improvement in hydration and texture for approved HA products
  • Little downtime
  • Does not add unwanted volume

Limitations

  • Category name hides very different products
  • Repeat cost
  • Non-approved products carry unknown risks

Common effects

  • Bumps and bruising
  • Redness
  • Temporary swelling

Serious risks

  • Infection or granulomas, especially with non-sterile or unapproved products
  • Vascular events with any injectable
  • Unknown long-term effects of unapproved biologics

Candidacy and pause signs

Usually considered for: Adults wanting subtle skin-quality change who can confirm the exact product and its U.S. status.

Pause before booking if

The product is imported, unnamed, mixed in-clinic, described as 'stem cell' or 'exosome' injection, or the provider cannot show U.S. approval or clearance for injection.

Operator, setting, and regulation

Who performs it in the U.S.: Physicians or advanced practitioners under physician oversight. Injecting unapproved products is a regulatory and safety problem regardless of the injector's credentials.

Regulatory status: Jurisdiction matters. In the U.S., check the FDA approved-fillers list for any HA product labeled for skin quality. Polynucleotide injectables are used under approvals in the U.K., E.U., and South Korea but are not FDA approved. No exosome product is approved for injection or for skin in the U.S.

Rules differ by state and by country. A product approved in one market may be unapproved in another, and the same device can be used within or outside its cleared indication.

Questions to ask before you pay a deposit

  1. What is the exact product name, and is it FDA approved or cleared for injection into skin?
  2. If it is approved abroad only, how did it reach this clinic?
  3. What controlled evidence supports it for my concern?

Open the complete safety checklist →

Sources on file

These links support the claims above. Reviewed September 1, 2026. Where a figure comes from a survey, the caveat is in the file, not in a footnote.

  1. U.S. FDA — list of FDA-approved dermal fillers (opens in a new tab)
  2. U.S. FDA — consumer alert on regenerative medicine products including exosomes (opens in a new tab)
  3. U.S. FDA — dermal fillers (soft tissue fillers) (opens in a new tab)
  4. American Academy of Dermatology — fillers overview (opens in a new tab)

Spot an error or a status change? Read how corrections and updates work →